[1]张伟 黄从新.巨噬细胞与心血管稳态和疾病[J].心血管病学进展,2019,(9):1241-1244.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.014]
 ZHANG Wei,HUANG Congxin.Macrophages are Associated with Cardiovascular Homeostasis and Diseases[J].Advances in Cardiovascular Diseases,2019,(9):1241-1244.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.014]
点击复制

巨噬细胞与心血管稳态和疾病()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2019年9期
页码:
1241-1244
栏目:
综述
出版日期:
2019-12-25

文章信息/Info

Title:
Macrophages are Associated with Cardiovascular Homeostasis and Diseases
作者:
张伟 黄从新
 (武汉大学人民医院心内科 武汉大学心血管病研究所 心血管病湖北重点实验室,湖北 武汉 430060 )
Author(s):
ZHANG Wei HUANG Congxin
(Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University ,Hubei Key Laboratory of Cardiology, Wuhan 430060, Hubei, China)
关键词:
巨噬细胞心血管稳态心血管疾病
Keywords:
Macrophage Cardiovascular homeostasis Cardiovascular diseases
DOI:
10.16806/j.cnki.issn.1004-3934.2019.09.014
摘要:
巨噬细胞是免疫系统的哨兵,分布于全身的所有组织中,除了抵御入侵的微生物,这些细胞还能识别、吞噬和消化衰老和受损的细胞、组织碎片和代谢产物。心脏巨噬细胞包括来自胚胎卵黄囊的心脏驻留巨噬细胞和来自血液中的单核-巨噬细胞,在心脏电传导、冠状动脉发育、心肌梗死后心室重构、心律失常及动脉粥样硬化中发挥着重要作用,现就近年来巨噬细胞在心血管稳态及疾病中的研究做一综述。

参考文献/References:


[1] Honold L, Nahrendorf M. Resident and monocyte-derived macrophages in cardiovascular disease[J]. Circ Res,2018,122(1):113-127.

[2] Lavine KJ, Pinto AR, Epelman S, et al. The macrophage in cardiac homeostasis and disease[J]. J Am Coll Cardiol,2018,72(18): 2213-2230.

[3] 王燕凤,蔡琳,汪汉.心肌组织中巨噬细胞的稳定性及特异性[J].心血管病学进展,2019,40(1):121-124.

[4] Bajpai G,Schneider C,Wong N, et al.The human heart contains distinct macrophage subsets with divergent origins and functions[J]. Nat Med,2018, 24(8): 1234-1245.

[5] Leid J, Carrelha J, Boukarabila H, et al. Primitive embryonic macrophages are required for coronary development and maturation[J].Circ Res,2016,118(10): 1498-1511.

[6] Epelman S, Lavine KJ, Beaudin AE, et al. Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation[J]. Immunity,2014,40(1):91-104.

[7] Lavine KJ, Epelman S, Uchida K, et al. Distinct macrophage lineages contribute to disparate patterns of cardiac recovery and remodeling in the neonatal and adult heart[J].Proc Nat l Acad Sci U S A ,2014,111(45):16029-16034.

[8] Li W,Hsiao H,Higashikubo R,et al. Heart-resident CCR2+ macrophages promote neutrophil extravasation through TLR9/MyD88/CXCL5 signaling[J]. JCI Insight,2016,1(12):e87315.

[9] Hulsmans M, Clauss S, Xiao L, et al. Macrophages facilitate electrical conduction in the heart[J]. Cell,2017,169(3):510-522.

[10] Ongstad E, Kohl P. Fibroblast–myocyte coupling in the heart: potential relevance for therapeutic interventions[J]. J Mol Cell Cardiol,2016, 91:238-246.

[11] Trembley MA, Velasquez LS, de Mesy Bentley KL, et al. Myocardin-related transcription factors control the motility of epicardium-derived cells and the maturation of coronary vessels[J]. Development,2014,142(1):21-30.

[12] Prabhu SD, Frangogiannis NG. The biological basis for cardiac repair after myocardial infarction[J]. Circ Res,2016,119(1):91-112.

[13] Frangogiannis NG. The inflammatory response in myocardial injury, repair, and remodelling[J]. Nat Rev Cardiol,2014,11(5):255-265.

[14] Bajpai G, Bredemeyer A, Li W, et al. Tissue resident CCR2? and CCR2+ cardiac macrophages differentially orchestrate monocyte recruitment and fate specification following myocardial injury [J]. Circ Res,2019,124(2): 263-278.

[15] Anzai A, Choi JL, He S, et al. The infarcted myocardium solicits GM-CSF for the detrimental oversupply of inflammatory leukocytes[J].J Experimental Medicine, 2017,214(11):3293-3310.

[16] King KR, Aguirre AD, Ye Y, et al. IRF3 and type I interferons fuel a fatal response to myocardial infarction[J]. Nat Med,2017,23(12):1481-1487.

[17] Cao DJ, Schiattarella GG, Villalobos E, et al. Cytosolic DNA sensing promotes macrophage transformation and governs myocardial ischemic injury[J]. Circulation,2018,137(24):2613-2634.

[18] Hilgendorf I, Gerhardt LMS, Tan TC, et al. Ly-6Chigh monocytes depend on Nr4a1 to balance both inflammatory and reparative phases in the infarcted myocardium[J]. Circ Res,2014,114(10):1611-1622.

[19] Monnerat G, Alarcón ML, Vasconcellos LR, et al. Macrophage-dependent IL-1β production induces cardiac arrhythmias in diabetic mice[J]. Nat Commun , 2016, 7:13344.

[20] Sun Z, Zhou D, Xie X, et al. Cross-talk between macrophages and atrial myocytes in atrial fibrillation[J]. Basic Res Cardiol ,2016,111(6) : 63.

[21] Kovács ?, Papp Z, Nagy L. Causes and pathophysiology of heart failure with preserved ejection fraction[J]. Heart Fail Clin ,2014,10(3):389-398.

[22] Hulsmans M, Sager HB, Roh JD, et al. Cardiac macrophages promote diastolic dysfunction[J]. J Exp Med,2018,215(2):423-440.

[23] Charo IF, Taub R. Anti-inflammatory therapeutics for the treatment of atherosclerosis[J]. Nat Rev Drug Discov ,2011,10(5):365-376.

[24] Moore KJ, Koplev S, Fisher EA, et al. Macrophage trafficking, inflammatory resolution, and genomics in atherosclerosis: JACC macrophage in CVD series (part 2)[J]. J Am Coll Cardiol,2018,72(18):2181-2197.

[25] Wolfs IM, Donners MM, de Winther MP. Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarisation[J]. Thromb Haemost,2011,106(5):763-771.

[26] Khallou-Laschet J, Varthaman A, Fornasa G, et al. Macrophage plasticity in experimental atherosclerosis[J]. PLoS One,2010,5(1):e8852.

[27] Rahman K, Vengrenyuk Y, Ramsey SA, et al. Inflammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regression[J]. J Clin Invest,2017,127(8):2904-2915.

[28] Moore KJ, Sheedy FJ, Fisher EA. Macrophages in atherosclerosis: a dynamic balance[J]. Nat Rev Immunol,2013,13(10):709-721.

[29] Bi Y, Chen J, Hu F, et al. M2 macrophages as a potential target for antiatherosclerosis treatment[J]. Neural Plast,2019,2019:6724903.

相似文献/References:

[1]李一凡 张智伟.巨噬细胞相关的外泌体在心血管疾病中的作用研究进展[J].心血管病学进展,2020,(8):839.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.014]
 LI Yifan,ZHANG Zhiwei.Role of Macrophage-Related Exosomes in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2020,(9):839.[doi:10.16806/j.cnki.issn.1004-3934.2020.08.014]
[2]陈远洋 王志维.供体巨噬细胞在心脏移植中的研究进展[J].心血管病学进展,2022,(6):514.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.009]
 CHEN Yuanyang,WANG Zhiwei.Donor Macrophages in Heart Transplantation[J].Advances in Cardiovascular Diseases,2022,(9):514.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.009]
[3]付韫韬 赵庆彦?/html>.巨噬细胞调控离子通道致心律失常研究的最新进展[J].心血管病学进展,2022,(2):100.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.002]
 FU Yuntao ZHAO Qingyan.Macrophages Regulating Ion Channels to Induce Arrhythmia[J].Advances in Cardiovascular Diseases,2022,(9):100.[doi:10.16806/j.cnki.issn.1004-3934.2022.02.002]
[4]陈乾 秦铭 徐志云.单核/巨噬细胞与主动脉瓣钙化研究进展[J].心血管病学进展,2022,(10):898.[doi:10.16806/j.cnki.issn.1004-3934.2022.10.008]
 CHEN Qian,QIN Ming,XU Zhiyun.Aortic Valve Calcification Caused by Mononuclear Phagocyte System[J].Advances in Cardiovascular Diseases,2022,(9):898.[doi:10.16806/j.cnki.issn.1004-3934.2022.10.008]
[5]王朝阳 赵丽娜 田师鹏 陈淑霞 谷剑.炎症治疗在动脉粥样硬化中的研究进展[J].心血管病学进展,2023,(6):519.[doi:10.16806/j.cnki.issn.1004-3934.2023.06.009]
 WANG Zhaoyang,ZHAO Lina,TIAN Shipeng,et al.Advances in the Treatment of Inflammation in Atherosclerosis[J].Advances in Cardiovascular Diseases,2023,(9):519.[doi:10.16806/j.cnki.issn.1004-3934.2023.06.009]
[6]黄爱宝??少衡.巨噬细胞治疗缺血心肌的研究进展[J].心血管病学进展,2024,(6):543.[doi:10.16806/j.cnki.issn.1004-3934.2024.06.015]
 HUANG Aibao,ZHANG Shaoheng?/html>.Research progress in Macrophage Therapy for?schemic Myocardium[J].Advances in Cardiovascular Diseases,2024,(9):543.[doi:10.16806/j.cnki.issn.1004-3934.2024.06.015]

更新日期/Last Update: 2020-02-06